Biotech · Private company
Strata Oncology
Track this companyFree. Adds Strata Oncology to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- axitinibPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- encorafenib + binimetinibPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Fam-Trastuzumab Deruxtecan-NxkiPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- lorlatinibPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- sacituzumab govitecanPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- talazoparibPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- StrataPATH™ (Precision Indications for Approved Therapies)PHASE2 · TERMINATED · started Apr 29, 2022ClinicalTrials.gov NCT05097599 · fetched Nov 12, 2026
- Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid TumorsTERMINATED · started Dec 3, 2021ClinicalTrials.gov NCT05082701 · fetched Nov 12, 2026
- Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid TumorsPHASE1 · COMPLETED · started Sep 24, 2019ClinicalTrials.gov NCT04087018 · fetched Nov 12, 2026
- Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid TumorsTERMINATED · started Nov 1, 2016ClinicalTrials.gov NCT03061305 · fetched Nov 12, 2026
- PROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerNA · ACTIVE_NOT_RECRUITING · started May 25, 2016ClinicalTrials.gov NCT02735252 · fetched Nov 12, 2026